Find News

Filter articles

Showing 81 to 90 of 3144 results

Gilead to buy Immunomedics for $21bn

US14-09-2020Sarah Morgan

Gilead Sciences is set to acquire biopharmaceutical company Immunomedics in a $21 billion deal, further strengthening its oncology expertise.

LSPN Connect: Invention harvesting

International14-09-2020Muireann Bolger

In the fast-paced environment of life sciences, the need for the IP sector to take full advantage of potential and emerging innovations is paramount, as a LSPN Connect session discovered.

Amyris facing $881m lawsuit over claims it broke contract

US11-09-2020Rory O'Neill

Cannabinoid maker Lavvan has filed a $881 million trade secrets lawsuit against pharmaceutical company Amyris.

EU concludes COVID-19 vaccine talks with Pfizer

EU10-09-2020Sarah Morgan

The European Commission has concluded exploratory talks with Pfizer and BioNTech to potentially supply 300 million doses of their investigational vaccine against COVID-19.

Ruling opens door for Noven’s oestrogen patch generics

US10-09-2020Sarah Morgan

In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.

Fed Circ grants Arthrex remand, rejects Iancu conflict

US10-09-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.

CRISPR babies still too risky, warns new report

US10-09-2020Legal developmentsMuireann Bolger

Human embryos whose genomes have been edited should not be used to create a pregnancy until it is certain that changes can be made without introducing undesired changes, according to a new report by an influential panel. 

Moderna’s COVID-19 and Zika patent applications to be investigated

US08-09-2020Legal developmentsMuireann Bolger

A US Department of Health and Human Services agency will investigate whether Moderna disclosed information on government funding in patent applications relating to its COVID-19 vaccine.

FTC demands AbbVie divests Crohn’s treatment in Allergan buyout

US07-09-2020Muireann Bolger

The US Federal Trade Commission has approved a final order regarding charges that biopharmaceutical company AbbVie’s $63 billion acquisition of Allergan would violate US federal antitrust law.

LSPN Connect: Protecting biologics at home and abroad

04-09-2020Rory O'Neill

Biologics are playing an increasingly important role in healthcare, but for corporate patent counsel, the differences in rules between the US and Europe are a real cause for concern.

Showing 81 to 90 of 3144 results